We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Profile: Thomas Lönngren.
- Authors
Louët, Sabine
- Abstract
The article profiles Thomas Lönngren, the executive director of Europe's principal regulatory agency, the European Medicines Agency (EMA). Previously, Lönngren was a director of operations for medicinal products at the Swedish Medical Products Agency in Uppsala. His diplomatic qualities have proved very useful in negotiating the cultural minefields encountered in the EMA's dealings with 25 national regulatory agencies. Lönngren believes that the current setback to follow-on biologics in Europe is only temporary. Legislation that was passed in June 2004 will allow generics companies to carry out development and clinical trials before the expiry of the patents of the original biologic products beginning in November 2005.
- Subjects
EUROPE; LONNGREN, Thomas; EXECUTIVES; BIOLOGICALS; LEGISLATIVE bills; CLINICAL trials
- Publication
Nature Biotechnology, 2004, Vol 22, Issue 11, p1341
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt1104-1341